Search

everythinglearnresearchcommunity

for

Search:↓

Diabetic neuropathy in mice is linked to poor mitochondria function and lower brain hormone production.

Finasteride affects brain processes related to neurotransmission and metabolism, potentially helping with neuropsychiatric conditions.

Genetic factors may influence how well valproic acid works and its side effects in epilepsy treatment.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

The lecture concluded that drugs for human enhancement are here to stay and called for their responsible development and fair access.

A man's relapsed leprosy was successfully treated with the antibiotic sparfloxacin.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Pregnancy and nursing increase certain brain activities in rats, but these changes disappear when the babies are taken away.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

Eflornithine improved symptoms in Bachmann–Bupp Syndrome patients.

Early diagnosis, stopping the suspected drug, and supportive care are crucial for treating Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

The current state and future directions of the field that studies the connection between the mind and skin are discussed.

Surgery may help infants with sagittal craniosynostosis develop more typical language processing.

Cerebronal® may help improve certain brain health markers.

Divalproex sodium significantly improved headaches in two-thirds of patients.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Bioactive compounds in neurocosmetics can improve skin health and emotional well-being.

New drug uses show promise but need more research.

Ethanol boosts brain steroid production by activating NMDA receptors, affecting memory formation.

Finasteride and dutasteride may cause depression and anxiety, especially in younger men.

Using electronic health records can help identify drug side effects but has some limitations.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Black cumin and its nanoformulations show promise in treating neurodegenerative diseases.

Long-term sodium valproate treatment for epilepsy generally caused mild and temporary side effects.

Patients with non-scarring hair loss often have emotional disorders.